AR
Insider
Andrew Reardon
CLO & SecretaryAndrew Reardon (CLO & Secretary) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $1.5M of LGND (4,796 sh across 6 lots, as filed), executed Jul 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.7M
shares × price, as filed
Last traded
Sep 3
Filed Sep 8
Median ADV $104.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
LGNDRecent filings
LGNDSALE
Ligand Pharmaceuticals Incorporated
View filing →
$199K2,000 sh × $99.60
Exec Sep 23 2024
Filed Sep 25 2024 · 5:30 PM ET